TY - JOUR
T1 - Corrigendum to “Feasibility and acceptability of Autism Adapted Safety Plans
T2 - an external pilot randomised controlled trial” (eClinicalMedicine (2024) 73, (S2589537024002414), (10.1016/j.eclinm.2024.102662))
AU - Rodgers, Jacqui
AU - Cassidy, Sarah
AU - Pelton, Mirabel
AU - Goodwin, Jane
AU - Nielsen, Emma
AU - Wagnild, Janelle
AU - Bhattarai, Nawaraj
AU - Gordon, Isabel
AU - Wilson, Colin
AU - Heslop, Phil
AU - Ogundimu, Emmanuel
AU - O'Connor, Rory C.
AU - Ramsay, Sheena E.
AU - Townsend, Ellen
AU - Vale, Luke
PY - 2025/6/1
Y1 - 2025/6/1
N2 - Dr Emma Nielsen was originally acknowledged in the paper. However, on discussion and reflection, and agreement with Dr Nielsen and all co-authors, we have added Dr Nielsen as a co-author in recognition of their contributions as a full-time post-doc during the first eight months of the study to methodology, investigation and project administration. Dr Nielsen has been added to the author list in the position shown above, and their affiliation is added to the affiliations list. Furthermore, mention of Dr Nielsen in the Acknowledgements section has now been removed. The Contributors and Declaration of interests sections have been updated as follows to add the respective information for EN. JR is the chief investigator who with SAC developed the study protocol alongside the other co-applicants (RC, ET, LV, SR, PH, EO, CW). JR and SC had overall responsibility for the management and delivery of the trial. EN and IG were the researchers at University of Nottingham and JG and MP were the researchers at Newcastle University. EN, IG and JG contributed to recruitment and data collection. MP and IG curated the data. Formal analysis was undertaken by JW, NB, IG and MP. The original draft of this paper was written by JR, SC, MP, JW, NB and IG. All authors reviewed the final submitted manuscript. JR, JW, NB, IG and MP accessed and verified the underlying data.
AB - Dr Emma Nielsen was originally acknowledged in the paper. However, on discussion and reflection, and agreement with Dr Nielsen and all co-authors, we have added Dr Nielsen as a co-author in recognition of their contributions as a full-time post-doc during the first eight months of the study to methodology, investigation and project administration. Dr Nielsen has been added to the author list in the position shown above, and their affiliation is added to the affiliations list. Furthermore, mention of Dr Nielsen in the Acknowledgements section has now been removed. The Contributors and Declaration of interests sections have been updated as follows to add the respective information for EN. JR is the chief investigator who with SAC developed the study protocol alongside the other co-applicants (RC, ET, LV, SR, PH, EO, CW). JR and SC had overall responsibility for the management and delivery of the trial. EN and IG were the researchers at University of Nottingham and JG and MP were the researchers at Newcastle University. EN, IG and JG contributed to recruitment and data collection. MP and IG curated the data. Formal analysis was undertaken by JW, NB, IG and MP. The original draft of this paper was written by JR, SC, MP, JW, NB and IG. All authors reviewed the final submitted manuscript. JR, JW, NB, IG and MP accessed and verified the underlying data.
UR - https://www.scopus.com/pages/publications/105005406324
U2 - 10.1016/j.eclinm.2025.103260
DO - 10.1016/j.eclinm.2025.103260
M3 - Comment/debate
AN - SCOPUS:105005406324
SN - 2589-5370
VL - 84
JO - EClinicalMedicine
JF - EClinicalMedicine
M1 - 103260
ER -
